Chief Financial Officer at Loxo Oncology
Dr. Dov A. Goldstein served as a member of our board of directors from July 2013 through October 2014, became our chief financial officer in July 2014 and is now our acting chief financial officer since February 2015. He has been a partner at Aisling Capital since 2008, except from July 2014 to January 2015, when he served as an Operating Partner at Aisling Capital. From 2006 to 2008, he was a Principal at Aisling Capital. From 2000 to 2005, Dr. Goldstein was Chief Financial Officer of Vicuron Pharmaceuticals, Inc. before its acquisition by Pfizer Inc. From 1998 to 2000, Dr. Goldstein was Director of Venture Analysis at HealthCare Ventures, a ...
Source: Loxo Oncology on 04/23/2015
By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Dov A. Goldstein M.D.. More specifically, you'll be able to:
Search for over 360,000 executive profiles.
Example: Dov A. Goldstein M.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.